Jonathan Anderman

General Counsel at COMPASS THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Jonathan Anderman is currently the Secretary, Vice President & Head-Legal at Compass Therapeutics, Inc. Prior to this, he worked as the Global Commercial Counsel at Biogen, Inc. from 2020 to 2021 and as the Assistant General Counsel at Intarcia Therapeutics, Inc. from 2015 to 2018.
Anderman received his undergraduate degree from The Pennsylvania State University and his graduate degree from Boston University School of Law.

Jonathan Anderman active positions

Companies	Position	Start
COMPASS THERAPEUTICS, INC.	General Counsel	31/07/2021

All active positions of Jonathan Anderman

Former positions of Jonathan Anderman

Companies	Position	End
BIOGEN INC.	Corporate Officer/Principal	31/07/2021
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Corporate Officer/Principal	31/07/2018

See the detail of Jonathan Anderman's experience

Training of Jonathan Anderman

Boston University School of Law	Graduate Degree
The Pennsylvania State University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonathan Anderman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
COMPASS THERAPEUTICS, INC.	Health Technology
BIOGEN INC.	Health Technology

Private companies	1
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Health Technology